Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Zymergen Inc (ZY) USD0.001

Sell:$13.80 Buy:$13.81 Change: $0.42 (3.14%)
Market closed |  Prices as at close on 23 September 2021 | Switch to live prices |
Change: $0.42 (3.14%)
Market closed |  Prices as at close on 23 September 2021 | Switch to live prices |
Change: $0.42 (3.14%)
Market closed |  Prices as at close on 23 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack that integrates techniques in molecular biology, chemistry, materials science, lab automation systems, software applications, databases and machine learning algorithms. Its biofacturing platform is designed to identify and create biomolecules and insert genes into a host microbe that produces the desired biomolecules. The Company serves to chemicals and materials, agriculture, and pharmaceuticals industries. The Company's product pipeline includes Electronics, Consumer Care, and Agriculture.

Contact details

6121 Hollis Street, Suite 700,
United States
+1 (415) 8018073

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.37 billion
Shares in issue:
102.39 million
Commodity Chemicals
United States
US dollar

Key personnel

  • Zach Serber
    Co-Founder, Chief Scientific Officer, Director
  • Jed Dean
    Co-Founder, Vice President - Operations and Engineering
  • Enakshi Singh
    Chief Financial Officer
  • Aaron Kimball
    Chief Technology Officer
  • Aindrea Campbell
    Chief Manufacturing Officer
  • Subodh Deshmukh
    Chief Development Officer
  • Lincoln Germain
    Chief Commercial Officer
  • Mina Kim
    Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.